[
  {
    "ts": null,
    "headline": "AM Best Assigns Credit Ratings to Care Improvement Plus South Central Insurance Company",
    "summary": "OLDWICK, N.J., February 03, 2026--AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of \"a+\" (Excellent) to Care Improvement Plus South Central Insurance Company (CIPSCIC) (Omaha, NE), a health insurance subsidiary of UnitedHealth Group Incorporated. The outlook assigned to these Credit Ratings (ratings) is stable.",
    "url": "https://finnhub.io/api/news?id=600a8ff0cc30d9a0bbbc532f98715a8958d6eaa74e069f033a5ded40a7c9556e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770148920,
      "headline": "AM Best Assigns Credit Ratings to Care Improvement Plus South Central Insurance Company",
      "id": 138347188,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "OLDWICK, N.J., February 03, 2026--AM Best has assigned a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of \"a+\" (Excellent) to Care Improvement Plus South Central Insurance Company (CIPSCIC) (Omaha, NE), a health insurance subsidiary of UnitedHealth Group Incorporated. The outlook assigned to these Credit Ratings (ratings) is stable.",
      "url": "https://finnhub.io/api/news?id=600a8ff0cc30d9a0bbbc532f98715a8958d6eaa74e069f033a5ded40a7c9556e"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Stock Could Reach New Heights by 2030: Here’s the Outlook",
    "summary": "Is the outlook for UnitedHealth (NYSE:UNH) stock healthy or ill? That’s the crucial question for concerned investors as the general sentiment remains low for this embattled healthcare provider. This might sound counterintuitive at first, but the fall-off in UNH stock could provide a multi-year investment opportunity. There’s no denying that the aging baby boomer population ... UnitedHealth Stock Could Reach New Heights by 2030: Here’s the Outlook",
    "url": "https://finnhub.io/api/news?id=64bcccb3cabb3566c2514a1af0fd7075af6c7a6ff8196f50acfc3c253e6bb0e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770143559,
      "headline": "UnitedHealth Stock Could Reach New Heights by 2030: Here’s the Outlook",
      "id": 138345621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Is the outlook for UnitedHealth (NYSE:UNH) stock healthy or ill? That’s the crucial question for concerned investors as the general sentiment remains low for this embattled healthcare provider. This might sound counterintuitive at first, but the fall-off in UNH stock could provide a multi-year investment opportunity. There’s no denying that the aging baby boomer population ... UnitedHealth Stock Could Reach New Heights by 2030: Here’s the Outlook",
      "url": "https://finnhub.io/api/news?id=64bcccb3cabb3566c2514a1af0fd7075af6c7a6ff8196f50acfc3c253e6bb0e6"
    }
  },
  {
    "ts": null,
    "headline": "Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?",
    "summary": "CNC heads into Q4 earnings with revenue growth expected, but declining membership and higher medical costs cloud the outlook.",
    "url": "https://finnhub.io/api/news?id=623072354c6a26404c97c8a187cfeb6da7195305fc1a8f4f4f2bb5494b5c4fe3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770140160,
      "headline": "Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?",
      "id": 138345622,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "CNC heads into Q4 earnings with revenue growth expected, but declining membership and higher medical costs cloud the outlook.",
      "url": "https://finnhub.io/api/news?id=623072354c6a26404c97c8a187cfeb6da7195305fc1a8f4f4f2bb5494b5c4fe3"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on McKesson: “When This Company Reports, Its Stock Usually Flies”",
    "summary": "McKesson Corporation (NYSE:MCK) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted what usually happens when the stock reports, as he said: Oh, and I have a wild card for you. The president’s on the warpath against all sorts of companies in the healthcare chain. You know, I mean, we saw […]",
    "url": "https://finnhub.io/api/news?id=62dd147847ebb16b2f006c092e12887e94295e138b00e2baa0cf4e9276688186",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770121451,
      "headline": "Jim Cramer on McKesson: “When This Company Reports, Its Stock Usually Flies”",
      "id": 138341668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "McKesson Corporation (NYSE:MCK) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted what usually happens when the stock reports, as he said: Oh, and I have a wild card for you. The president’s on the warpath against all sorts of companies in the healthcare chain. You know, I mean, we saw […]",
      "url": "https://finnhub.io/api/news?id=62dd147847ebb16b2f006c092e12887e94295e138b00e2baa0cf4e9276688186"
    }
  },
  {
    "ts": null,
    "headline": "Is It Time To Reassess UnitedHealth Group (UNH) After Its Sharp Share Price Slide?",
    "summary": "If you are wondering whether UnitedHealth Group's current price reflects its true worth, you are not alone, especially with healthcare stocks drawing close attention from valuation focused investors. The stock last closed at US$285.59, with returns of an 18.8% decline over 7 days, a 15.1% decline over 30 days, a 15.1% decline year to date, a 46.6% decline over 1 year and a 36.5% decline over 3 years, plus a 4.5% decline over 5 years, which naturally raises questions about risk and...",
    "url": "https://finnhub.io/api/news?id=c2fa3f3b9fdf2e35078e055ff31b02cb2e0c5793a5fdd684571866293209b1f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770120536,
      "headline": "Is It Time To Reassess UnitedHealth Group (UNH) After Its Sharp Share Price Slide?",
      "id": 138341669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "If you are wondering whether UnitedHealth Group's current price reflects its true worth, you are not alone, especially with healthcare stocks drawing close attention from valuation focused investors. The stock last closed at US$285.59, with returns of an 18.8% decline over 7 days, a 15.1% decline over 30 days, a 15.1% decline year to date, a 46.6% decline over 1 year and a 36.5% decline over 3 years, plus a 4.5% decline over 5 years, which naturally raises questions about risk and...",
      "url": "https://finnhub.io/api/news?id=c2fa3f3b9fdf2e35078e055ff31b02cb2e0c5793a5fdd684571866293209b1f0"
    }
  },
  {
    "ts": null,
    "headline": "Bernstein Reiterates Outperform on UnitedHealth (UNH) Amid Medicare Advantage Volatility",
    "summary": "UnitedHealth Group Incorporated (NYSE:UNH) ranks among the stocks with the lowest forward PE ratios. Following notable stock volatility caused by Medicare Advantage (MA) advance rate announcements, Bernstein SocGen Group reiterated its Outperform rating and $405 price target for UnitedHealth Group Incorporated (NYSE:UNH) on January 30. Analyst Lance Wilkes noted five key market questions regarding this, […]",
    "url": "https://finnhub.io/api/news?id=7d37b9b8718574f3c0b6f6669de8918a876fa35a1aaffc893593b5f7d4b5f8c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770113517,
      "headline": "Bernstein Reiterates Outperform on UnitedHealth (UNH) Amid Medicare Advantage Volatility",
      "id": 138340769,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth Group Incorporated (NYSE:UNH) ranks among the stocks with the lowest forward PE ratios. Following notable stock volatility caused by Medicare Advantage (MA) advance rate announcements, Bernstein SocGen Group reiterated its Outperform rating and $405 price target for UnitedHealth Group Incorporated (NYSE:UNH) on January 30. Analyst Lance Wilkes noted five key market questions regarding this, […]",
      "url": "https://finnhub.io/api/news?id=7d37b9b8718574f3c0b6f6669de8918a876fa35a1aaffc893593b5f7d4b5f8c9"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From UnitedHealth’s Q4 Earnings Call",
    "summary": "UnitedHealth’s fourth quarter results were met with a significant negative market reaction, as management highlighted ongoing challenges in its Medicare Advantage and Medicaid businesses. CEO Stephen Hemsley described 2025 as a year of “critical self-examination,” emphasizing actions to rightsize membership, reprioritize margin over volume, and address operational inconsistencies—particularly within OptumHealth. Both Hemsley and UnitedHealthcare CEO Timothy Noel pointed to elevated medical cost",
    "url": "https://finnhub.io/api/news?id=b19ce2750914c572f9ccccb533a220a3623bed2c19ee56c56deea80893163fc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770096800,
      "headline": "The Top 5 Analyst Questions From UnitedHealth’s Q4 Earnings Call",
      "id": 138340058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth’s fourth quarter results were met with a significant negative market reaction, as management highlighted ongoing challenges in its Medicare Advantage and Medicaid businesses. CEO Stephen Hemsley described 2025 as a year of “critical self-examination,” emphasizing actions to rightsize membership, reprioritize margin over volume, and address operational inconsistencies—particularly within OptumHealth. Both Hemsley and UnitedHealthcare CEO Timothy Noel pointed to elevated medical cost",
      "url": "https://finnhub.io/api/news?id=b19ce2750914c572f9ccccb533a220a3623bed2c19ee56c56deea80893163fc9"
    }
  }
]